Schedule 13G ownership disclosure
Brickell Biotech, Inc.
Security class unavailable · CUSIP: 10802T105
Event date: 2021-07-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,708,050
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-21-000273
- Form type
- SC 13G
- Filer
- Fresh Tracks Therapeutics, Inc.
- CIK
- CIK 819050
- Filed
- Jul 22, 2021
- Reporting period
- Jul 22, 2021
- Description
- Schedule 13G beneficial ownership